Grant of Interim Extension of the Term of U.S. Patent No. 5,686,060; LUMASONTM, 53174-53175 [2014-21308]

Download as PDF 53174 Federal Register / Vol. 79, No. 173 / Monday, September 8, 2014 / Notices Dated: September 2, 2014. Tracey L. Thompson, Acting Deputy Director, Office of Sustainable Fisheries, National Marine Fisheries Service. [FR Doc. 2014–21246 Filed 9–5–14; 8:45 am] BILLING CODE 3510–22–P regulatory process, regulatory discards and the EU landings obligation, and cost recovery/cost sharing models. The meeting will include discussion of various MAFAC administrative and organizational matters and may include meetings of the standing subcommittees. Special Accommodations DEPARTMENT OF COMMERCE National Oceanic and Atmospheric Administration RIN 0648–XD435 Marine Fisheries Advisory Committee Meeting National Marine Fisheries Service (NMFS), National Oceanic and Atmospheric Administration (NOAA), Commerce. ACTION: Notice of open public meeting. AGENCY: The meeting is physically accessible to people with disabilities. Requests for sign language interpretation or other auxiliary aids should be directed to Heidi Lovett, Acting MAFAC Executive Director; 301–427–8004 by September 16, 2014. Dated: September 3, 2014. Eileen Sobeck, Assistant Administrator for Fisheries, National Marine Fisheries Service. [FR Doc. 2014–21315 Filed 9–5–14; 8:45 am] BILLING CODE 3510–22–P This notice sets forth the proposed schedule and agenda of a forthcoming meeting of the Marine Fisheries Advisory Committee (MAFAC). The members will discuss and provide advice on issues outlined under SUPPLEMENTARY INFORMATION below. SUMMARY: DEPARTMENT OF COMMERCE United States Patent and Trademark Office Submission for OMB Review; Comment Request The meeting will be held September 23–25, 2014 from 8 a.m. to 5 p.m. ADDRESSES: The meeting will be held at the Silver Spring Civic Center, One Veterans Plaza, Silver Spring, MD 20910; 240–777–5350. FOR FURTHER INFORMATION CONTACT: Heidi Lovett, Acting MAFAC Executive Director; (301) 427–8004; email: Heidi.Lovett@noaa.gov. SUPPLEMENTARY INFORMATION: As required by section 10(a)(2) of the Federal Advisory Committee Act, 5 U.S.C. App. 2, notice is hereby given of a meeting of MAFAC. The MAFAC was established by the Secretary of Commerce (Secretary), and, since 1971, advises the Secretary on all living marine resource matters that are the responsibility of the Department of Commerce. The complete charter and summaries of prior meetings are located online at https://www.nmfs.noaa.gov/ ocs/mafac/. DATES: rmajette on DSK2TPTVN1PROD with NOTICES Matters To Be Considered This meeting time and agenda are subject to change. The meeting is convened to hear presentations and discuss policies and guidance on the following topics: Improving recovery of protected resources, recreational fisheries policy, the proposed rule for the aquaculture plan for Federal waters of the Gulf of Mexico, climate science advice and the VerDate Mar<15>2010 15:14 Sep 05, 2014 Jkt 232001 The United States Patent and Trademark Office (USPTO) will submit to the Office of Management and Budget (OMB) for clearance the following proposal for collection of information under the provisions of the Paperwork Reduction Act (44 U.S.C. Chapter 35). Agency: United States Patent and Trademark Office (USPTO). Title: Admittance to Practice. Agency Approval Number: 0651– 0012. Type of Request: Revision of a currently approved collection. Burden: 34,773 hours annually. Number of Respondents: 21,860 responses per year. Avg. Hours per Response: The USPTO estimates that it will take the public approximately 3 minutes (0.05 hours) to 40 hours to prepare the appropriate form or documents and submit to the USPTO. Needs and Uses: The OED director uses the information in this collection to determine whether the applicate is of good moral character and repute; has the necessary legal, scientific, and technical qualifications; and is otherwise competent to advise and assist applicants in the presentation and prosecution of patent applications. The USPTO uses applicate information in determining whether an applicant may be added to, or an existing practitioner may remain on, the Register of Patent Attorneys and Agents. PO 00000 Frm 00013 Fmt 4703 Sfmt 4703 Affected Public: Businesses or other for-profit organizations. Frequency: On occasion. Respondent’s Obligation: Required to obtain or retain benefits. OMB Desk Officer: Nicholas A. Fraser, email: Nicholas_A._Fraser@ omb.eop.gov. Once submitted, the request will be publicly available in electronic format through the Information Collection Review page at www.reginfo.gov. Paper copies can be obtained by: • Email: InformationCollection@ uspto.gov. Include ‘‘0651–0012 copy request’’ in the subject line of the message. • Mail: Margaret McElrath, Deputy Director, Office of Information Management Services, Office of the Chief Information Officer, United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313–1450. Written comments and recommendations for the proposed information collection should be sent on or before October 8, 2014 to Nicholas A. Fraser, OMB Desk Officer, via email to Nicholas_A._Fraser@omb.eop.gov, or by fax to 202–395–5167, marked to the attention of Nicholas A. Fraser. Dated: September 2, 2014. Margaret McElrath, Deputy Director, Office of Information Management Services, Office of the Chief Information Officer. [FR Doc. 2014–21274 Filed 9–5–14; 8:45 am] BILLING CODE 3510–16–P DEPARTMENT OF COMMERCE United States Patent and Trademark Office [Docket No.: PTO–P–2014–0028] Grant of Interim Extension of the Term of U.S. Patent No. 5,686,060; LUMASONTM (sulfur hexafluoride microbubble) United States Patent and Trademark Office, Commerce. ACTION: Notice of Interim Patent Term Extension. AGENCY: The United States Patent and Trademark Office has issued an order granting interim extension under 35 U.S.C. 156(d)(5) for a one-year interim extension of the term of U.S. Patent No. 5,686,060. FOR FURTHER INFORMATION CONTACT: Mary C. Till by telephone at (571) 272– 7755; by mail marked to her attention and addressed to the Commissioner for Patents, Mail Stop Hatch-Waxman PTE, P.O. Box 1450, Alexandria, VA 22313– SUMMARY: E:\FR\FM\08SEN1.SGM 08SEN1 Federal Register / Vol. 79, No. 173 / Monday, September 8, 2014 / Notices 1450; by fax marked to her attention at (571) 273–7755; or by email to Mary.Till@uspto.gov. Section 156 of Title 35, United States Code, generally provides that the term of a patent may be extended for a period of up to five years if the patent claims a product, or a method of making or using a product, that has been subject to certain defined regulatory review, and that the patent may be extended for interim periods of up to one year if the regulatory review is anticipated to extend beyond the expiration date of the patent. On May 13, 2014, Bracco Suisse SA, the patent owner of record, timely filed an application under 35 U.S.C. § 156(d)(5) for an interim extension of the term of U.S. Patent No. 5,686,060. The patent claims the human drug product LUMASONTM, sulfur hexafluoride microbubbles. The application indicates that Bracco Diagnostics Inc., an affiliate of patent owner Bracco Suisse SA, initially submitted a New Drug Application (NDA) #21–315 to the Food and Drug Administration (FDA) on January 21, 2001, and withdrew NDA #21–315 on December 20, 2007. Bracco Diagnostics Inc. submitted a new NDA #203–684 on December 20, 2011. FDA accepted NDA 203–684 for filing on February 19, 2012. Review of the application indicates that, except for permission to market or use the product commercially, the subject patent would be eligible for an extension of the patent term under 35 U.S.C. 156, and that the patent should be extended for one year as required by 35 U.S.C. 156(d)(5)(B). Because the regulatory review period will continue beyond the original expiration date of the patent, November 11, 2014, interim extension of the patent term under 35 U.S.C. 156(d)(5) is appropriate. An interim extension under 35 U.S.C. 156(d)(5) of the term of U.S. Patent No. 5,686,060 is granted for a period of one year from the original expiration date of the patent. rmajette on DSK2TPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: Dated: August 26, 2014. Andrew Hirshfeld. Deputy Commissioner for Patent Examination Policy, United States Patent and Trademark Office. [FR Doc. 2014–21308 Filed 9–5–14; 8:45 am] BILLING CODE 3510–16–P VerDate Mar<15>2010 15:14 Sep 05, 2014 Jkt 232001 COMMODITY FUTURES TRADING COMMISSION Sunshine Act Meetings 10:30 a.m., Thursday, September 11, 2014. PLACE: 1155 21st St. NW., Washington, DC, 9th Floor Commission Conference Room. STATUS: Closed. MATTERS TO BE CONSIDERED: Surveillance, Enforcement Matters, and Examinations. In the event that the times, dates, or locations of this or any future meetings change, an announcement of the change, along with the new time and place of the meeting will be posted on the Commission’s Web site at https://www.cftc.gov. CONTACT PERSON FOR MORE INFORMATION: Christopher J. Kirkpatrick, 202–418– 5964. TIME AND DATE: Christopher J. Kirkpatrick, Secretary of the Commission. [FR Doc. 2014–21400 Filed 9–4–14; 4:15 pm] BILLING CODE 6351–01–P DEPARTMENT OF DEFENSE Department of the Army Army Education Advisory Committee Meeting Notice Department of the Army, DoD. ACTION: Notice of open committee meeting. 53175 Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.150. Purpose of the Meeting: The purpose of the meeting is to collect and analyze corporate and academia best practices for dealing with sexual harassment and assault. Proposed Agenda: October 8–9: The committee is chartered to provide independent advice and recommendations to the Secretary of the Army on the educational, doctrinal, and research policies and activities of U.S. Army educational programs. The committee will review and evaluate information related to dealing with sexual harassment and assault, and explore cultural issues affecting sexual harassment and assault. The committee will discuss societal norms, generational differences, changes in cultural dynamics, and sexual attitudes that may impact the Army’s culture. Public Accessibility to the Meeting: Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102–3.140 through 102– 3.165, and subject to the availability of space, this meeting is open to the public. Seating is on a first to arrive basis. Attendees are requested to submit their name, affiliation, and daytime phone number seven business days prior to the meeting to Mr. Joyner, via electronic mail, the preferred mode of submission, at the address listed in the AGENCY: FOR FURTHER INFORMATION CONTACT The Department of the Army is publishing this notice to announce the following Federal advisory committee meeting of the Army Education Advisory Committee. This meeting is open to the public. DATES: The Army Education Advisory Committee will meet from 8:00 a.m. to 5:00 p.m. on October 8 and 9, 2014 and from 8:00 a.m. to 2:00 p.m. on October 10, 2014. ADDRESSES: Army Education Advisory Committee, U.S. Training Doctrine Command, Building 950, Conference Room 2014, Fort Eustis, VA 23604. FOR FURTHER INFORMATION CONTACT: Mr. Wayne Joyner, the Designated Federal Officer for the committee, in writing at ATTN: ATTG–ZC, U.S. Training Doctrine Command, 950 Jefferson Ave, Fort Eustis, VA 23604, by email at albert.w.joyner.civ@mail.mil, or by telephone at (757) 501–5810. SUPPLEMENTARY INFORMATION: The committee meeting is being held under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., section. Because the meeting of the committee will be held in a Federal Government facility on a military base, security screening is required. A photo ID is required to enter base. Please note that security and gate guards have the right to inspect vehicles and persons seeking to enter and exit the installation. U.S. Training Doctrine Command is fully handicap accessible. Wheelchair access is available in front at the main entrance of the building. For additional information about public access procedures, contact Mr. Joyner, the committee’s Designated Federal Officer, at the email address or telephone number listed in the FOR FURTHER INFORMATION CONTACT section. Written Comments or Statements: Pursuant to 41 CFR 102–3.105(j) and 102–3.140 and section 10(a)(3) of the Federal Advisory Committee Act, the public or interested organizations may submit written comments or statements to the committee, in response to the stated agenda of the open meeting or in regard to the committee’s mission in general. Written comments or statements should be submitted to Mr. Joyner the committee Designated SUMMARY: PO 00000 Frm 00014 Fmt 4703 Sfmt 4703 E:\FR\FM\08SEN1.SGM 08SEN1

Agencies

[Federal Register Volume 79, Number 173 (Monday, September 8, 2014)]
[Notices]
[Pages 53174-53175]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-21308]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

United States Patent and Trademark Office

[Docket No.: PTO-P-2014-0028]


Grant of Interim Extension of the Term of U.S. Patent No. 
5,686,060; LUMASONTM (sulfur hexafluoride microbubble)

AGENCY: United States Patent and Trademark Office, Commerce.

ACTION: Notice of Interim Patent Term Extension.

-----------------------------------------------------------------------

SUMMARY: The United States Patent and Trademark Office has issued an 
order granting interim extension under 35 U.S.C. 156(d)(5) for a one-
year interim extension of the term of U.S. Patent No. 5,686,060.

FOR FURTHER INFORMATION CONTACT: Mary C. Till by telephone at (571) 
272-7755; by mail marked to her attention and addressed to the 
Commissioner for Patents, Mail Stop Hatch-Waxman PTE, P.O. Box 1450, 
Alexandria, VA 22313-

[[Page 53175]]

1450; by fax marked to her attention at (571) 273-7755; or by email to 
Mary.Till@uspto.gov.

SUPPLEMENTARY INFORMATION: Section 156 of Title 35, United States Code, 
generally provides that the term of a patent may be extended for a 
period of up to five years if the patent claims a product, or a method 
of making or using a product, that has been subject to certain defined 
regulatory review, and that the patent may be extended for interim 
periods of up to one year if the regulatory review is anticipated to 
extend beyond the expiration date of the patent.
    On May 13, 2014, Bracco Suisse SA, the patent owner of record, 
timely filed an application under 35 U.S.C. Sec.  156(d)(5) for an 
interim extension of the term of U.S. Patent No. 5,686,060. The patent 
claims the human drug product LUMASONTM, sulfur hexafluoride 
microbubbles. The application indicates that Bracco Diagnostics Inc., 
an affiliate of patent owner Bracco Suisse SA, initially submitted a 
New Drug Application (NDA) 21-315 to the Food and Drug 
Administration (FDA) on January 21, 2001, and withdrew NDA 21-
315 on December 20, 2007. Bracco Diagnostics Inc. submitted a new NDA 
203-684 on December 20, 2011. FDA accepted NDA 203-684 for 
filing on February 19, 2012.
    Review of the application indicates that, except for permission to 
market or use the product commercially, the subject patent would be 
eligible for an extension of the patent term under 35 U.S.C. 156, and 
that the patent should be extended for one year as required by 35 
U.S.C. 156(d)(5)(B). Because the regulatory review period will continue 
beyond the original expiration date of the patent, November 11, 2014, 
interim extension of the patent term under 35 U.S.C. 156(d)(5) is 
appropriate.
    An interim extension under 35 U.S.C. 156(d)(5) of the term of U.S. 
Patent No. 5,686,060 is granted for a period of one year from the 
original expiration date of the patent.

    Dated: August 26, 2014.
Andrew Hirshfeld.
Deputy Commissioner for Patent Examination Policy, United States Patent 
and Trademark Office.
[FR Doc. 2014-21308 Filed 9-5-14; 8:45 am]
BILLING CODE 3510-16-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.